Key result
Procaine inhibits wild-type HERG channels in a concentration-, voltage-, and state-dependent manner with an IC50 of 34.79 μM, while mutations Y652A and F656A significantly reduce this blockade.
Effect estimate: IC50 34.79 μM
Procaine inhibits HERG channels in a state-dependent manner, with the interaction significantly dependent on the Y652 and F656 residues in the S6 transmembrane domain.
May warrant QT-prolongation caution with procaine; leaves open clinical arrhythmia risk and human translation.
The article evaluated the inhibitory action of procaine on wild-type and mutated HERG potassium channel current (I(HERG)) to determine whether mutations in the S6 region are important for the inhibition of I(HERG) by procaine. HERG channels (WT, Y652A, and F656A) were expressed in Xenopus laevis oocytes and studied using the standard two-microelectrode voltage-clamp technique. The results revealed that WT HERG is blocked in a concentration-, voltage-, and state-dependent manner by procaine ([IC₅₀] = 34.79 μM). The steady state activation curves slightly move to the negative, while inactivation parameters move to the positive in the presence of procaine. Time-dependent test reveals that voltage-dependent I(HERG) blockade occurs extremely rapidly. Furthermore, the mutation to Ala of Y652 and F656 produce about 11-fold and 18-fold increases in IC₅₀ for I(HERG) blockade, respectively. Simultaneously, for Y652A, the steady state activation and inactivation parameters are shifted to more positive values after perfusion of procaine. Conclusively, procaine state-dependently inhibits HERG channels (WT, Y652A, and F656A). The helix residues Y652 and F656 in the S6 transmembrane domain might play a role in interaction of the drug with the channel.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2013) studied HERG channel blockade. Procaine vs. Control (absence of procaine) was evaluated on IC50 for HERG channel blockade (IC50 34.79 μM). Procaine inhibits wild-type HERG channels in a concentration-, voltage-, and state-dependent manner with an IC50 of 34.79 μM, while mutations Y652A and F656A significantly reduce this blockade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: